Showing 581 - 600 results of 4,739 for search '"malignancy"', query time: 0.10s Refine Results
  1. 581
  2. 582
  3. 583
  4. 584

    Humoral Hypercalcemia of Malignancy with a Parathyroid Hormone-Related Peptide-Secreting Intrahepatic Cholangiocarcinoma Accompanied by a Gastric Cancer by Katsushi Takeda, Ryosuke Kimura, Nobuhiro Nishigaki, Shinya Sato, Asami Okamoto, Kumiko Watanabe, Sachie Yasui

    Published 2017-01-01
    “…Humoral hypercalcemia of malignancy (HHM) is caused by the oversecretion of parathyroid hormone-related peptide (PTHrP) from malignant tumors. …”
    Get full text
    Article
  5. 585

    Diagnostic Accuracy of Immunologic Biomarkers for Accurate Diagnosis of Bloodstream Infection in Patients with Malignancy: Procalcitonin in Comparison with C-Reactive Protein by Mansoureh Shokripour, Navid Omidifar, Kourosh Salami, Mohsen Moghadami, Babak Samizadeh

    Published 2020-01-01
    “…To calculate the diagnostic value of C-reactive protein (CRP) and serum procalcitonin (PCT) levels for the pathologic presence of microbes in the bloodstream of patients with malignancy, in comparison with blood culture. Methodology. …”
    Get full text
    Article
  6. 586
  7. 587
  8. 588

    Atypical (symplastic) uterine leiomyoma masquerading as endometrial malignancy in a 78-year-old post-menopausal Nigerian woman by John Nwadiokwu, Elizabeth Grillo, Victor Okebalama, Olutomiwa Omokore, Obinna Onwe, Aaron Uka, Jennifer Ibhiedu, Samuel Okore, Nneoma Nwanna, Chiomaefuelim Dibie

    Published 2024-12-01
    “…Conclusion: Despite their rarity in postmenopausal women, atypical fibroids should be considered in the differential diagnosis for postmenopausal bleeding. Considering the malignant transformation potential, recurrence risk of this pathology, and the completion of family size in this case, hysterectomy is the most preferred treatment option even though myomectomy can be offered to patients with plans of conception in the future. …”
    Get full text
    Article
  9. 589
  10. 590
  11. 591
  12. 592

    Rate of malignancy for thyroid nodules with AUS/FLUS cytopathology in a tertiary care center – a retrospective cohort study by Kalpesh Hathi, Tarek Rahmeh, Vicki Munro, Victoria Northrup, Ali Sherazi, Christopher J. Chin

    Published 2021-10-01
    “…In total, 24 thyroid nodules were deemed malignant upon histopathology, yielding a final malignancy rate of 13.2–25.3%. …”
    Get full text
    Article
  13. 593
  14. 594

    Reconstruction of Upper Eyelid Defects Secondary to Malignant Tumors with a Newly Modified Cutler-Beard Technique with Tarsoconjunctival Graft by Álvaro Bengoa-González, Bianca Ma Laslău, Agustín Martín-Clavijo, Enrique Mencía-Gutiérrez, Ma Dolores Lago-Llinás

    Published 2019-01-01
    “…We describe a modification of Cutler-Beard’s technique, using a contralateral tarsoconjunctival graft, in patients who underwent excision of large malignant tumors of the upper eyelid. Methods. This is an interventional retrospective review (clinical study) of ten cases, with age range from 64 to 86 years (mean: 71.2 years ± 6.49) with malignant upper eyelid tumors, operated by the same surgeon (AB-G), between 2011 and 2016. …”
    Get full text
    Article
  15. 595

    Unusual Case of Malignant Struma Ovarii and Cervical Thyroid Cancer Preceded by Ovarian Teratoma: Case Report and Review of the Literature by Elias G. Tzelepis, Elena Barengolts, Steven Garzon, Joseph Shulan, Yuval Eisenberg

    Published 2019-01-01
    “…To present a rare case of malignant struma ovarii (MSO) and synchronous thyroid cancer, review the medical literature, and present the latest trends in management. …”
    Get full text
    Article
  16. 596
  17. 597

    Machine learning identifies the association between second primary malignancies and postoperative radiotherapy in young-onset breast cancer patients. by Yulin Lai, Peiyuan Huang

    Published 2025-01-01
    “…<h4>Background</h4>A second primary malignant tumor is one of the most important factors affecting the long-term survival of young women with breast cancer (YWBC). …”
    Get full text
    Article
  18. 598
  19. 599
  20. 600

    Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea by Joon Min Jung, Do Hyung Kim, Ye-Jee Kim, Ik Jun Moon, Woo Jin Lee, Sung Eun Chang, Mi Woo Lee, Chong Hyun Won

    Published 2025-01-01
    “…Abstract There is limited data on the risk of second primary malignancies (SPMs) in Asian melanoma survivors. This study aimed to identify the risk of SPMs in Asian melanoma survivors. …”
    Get full text
    Article